Temodar, a medication used to treat multiple sclerosis (MS), will be shipped to India for the first time by Amgen (AMGN), according to Biomedicine Today. Two thirds of all cancer medications prescribed in India come from MS, making it the country's main provider of cancer medications. The second-biggest source is MS. Apart from Amgen's associate Cipla in India, Novartis is an additional enterprise that supplies biopharmaceuticals, encompassing the MS medication, to India. In 2014, the two major pharmaceutical companies announced their intention to collaborate.